Emerging psychoactive substances appear faster than legislation can track them. This guide explains how new compounds enter the European market, how EU monitoring systems respond, and what the shifting NPS landscape means for researchers, laboratories, and public health.
Tag Archives: designer drugs explained
Research chemicals explained from the ground up: where the term came from, what it actually means today, how these compounds are classified, and why European regulation treats them as a moving target. A plain-language educational overview for curious readers, students, and laboratory professionals.
Research chemical classifications organise a vast and fast-changing landscape of novel psychoactive substances into meaningful chemical families. This guide explains the major classes, how they differ pharmacologically, and why accurate identification matters for laboratory and regulatory contexts across Europe.